By Market & Region

Santa Cruz, Calif. – October 02, 2026 -- Emboline, Inc. completed the first commercial use of its Emboliner® Embolic Protection System in the United States on October 1, 2026, just weeks after receiving U.S. Food and Drug Administration 510(k) clearance.

Two TAVR procedures mark Emboline's commercial debut

The device was deployed during two transcatheter aortic valve implantation (TAVR) procedures performed by Tamim Nazif, MD, Co-Director of the Structural Heart and Valve Center at New York-Presbyterian/Columbia University Irving Medical Center. Dr. Nazif also serves as Co-Principal Investigator of the PROTECT H2H clinical trial, which evaluated the Emboliner's performance ahead of regulatory approval.

Los Angeles – October 02, 2026 -- Loyola Marymount University has received a $5.57 million gift from the Marymount Education Foundation (MEF), the largest contribution to date to its LMU Catholic High School Promise Program.

Gift funds up to 18 new scholarships annually across six partner high schools

The donation establishes the Marymount Scholars Program, a partnership between LMU, MEF and the Archdiocese of Los Angeles designed to guarantee admission and comprehensive financial support for qualified Catholic high school seniors. The program will support up to 18 new students each year from six participating schools: Bishop Conaty–Our Lady of Loretto High School, Bishop Mora Salesian, Cantwell–Sacred Heart of Mary College Prep, Junípero Serra High School, St. Bernard College Prep, and St. Pius X–St. Matthias Academy.

Grand Rapids, Mich. – October 02, 2026 -- Parkway Electric & Communications has transitioned to 100% employee ownership through an Employee Stock Ownership Plan (ESOP), ending nearly 24 years of ownership by Huizenga Group. The announcement was made to employees on September 15 at the company's annual meeting held at the Pinnacle Center.

Huizenga Group chose employee ownership over an outside sale

Huizenga Group, a privately held West Michigan investment firm, acquired Parkway in December 2002. As the firm weighed the company's long-term future, it considered a potential sale to an outside buyer but ultimately opted for the ESOP structure to preserve Parkway's independence, culture and customer relationships. "We concluded that the best way to honor that legacy was to transition ownership to the employees themselves," said J.C. Huizenga, Chairman of Huizenga Group.

San Diego – – October 02, 2026 -- A national survey of 5,000 U.S. adults has found that Americans rate a family birthday party as a more awkward setting for discussing inheritance than a funeral, upending assumptions about when families confront estate planning. Trust & Will's 2026 Death & Inheritance Report found 63% of respondents call a birthday the most awkward occasion for the conversation, compared with 41% for a funeral or wake and just 32% for an ordinary phone call.

Christmas ranks as both the top trigger and the top occasion families avoid

Christmas is the most common holiday prompt for inheritance discussions, cited by 16% of respondents, yet it is simultaneously the occasion Americans most actively avoid for the same topic, at 37% -- more than double any other occasion and the top avoidance answer in all 50 states.

Palma de Mallorca, Spain – October 02, 2026 -- Smartee Denti-Technology concluded its first large-scale academic summit held outside China on September 19, drawing nearly 300 orthodontic clinicians from 27 countries to Palma de Mallorca and unveiling two new clear-aligner product systems for international markets.

Smartee debuts SA/SA Plus and AG KIDS systems at two-day event

The Smartee European Summit 2026 served as the international launch platform for Smartee SA/SA Plus, a clear-aligner system incorporating a locking mechanism to address primary snoring and mild-to-moderate obstructive sleep apnea alongside orthodontic treatment. The company also introduced Smartee AG KIDS, a craniofacial growth guidance system for patients aged 3 to 16 that targets sagittal, vertical and transverse growth management paired with orofacial myofunctional training appliances.

Cambridge, Mass. – October 02, 2026 -- Marengo Therapeutics will present interim results from its STARt-002 trial combining invikafusp alfa with Gilead's TRODELVY (sacituzumab govitecan-hziy) at the Society for Immunotherapy of Cancer's 41st Annual Meeting in Phoenix, Arizona, November 4-8, 2026.

STARt-002 pairs a T-cell agonist with an antibody-drug conjugate for the first time in clinical testing

The Phase 1b/2 study tests invikafusp alfa, a Vβ6-selective dual T-cell agonist, alongside TRODELVY's TROP2-directed cytotoxic payload delivery. Marengo's Chief Medical Officer Kevin Chin said the ADC is designed to release tumor antigens and inflame the tumor microenvironment, priming less immunogenic tumors for T-cell-mediated responses that invikafusp alfa can then amplify.

Delray Beach – October 02, 2026 -- The global emulsifiers market is projected to climb to USD 18.15 billion by 2031, up from USD 12.15 billion in 2026, expanding at a compound annual growth rate of 8.4%, according to MarketsandMarkets.

Food applications drive demand as processed food consumption rises worldwide

Food emulsifiers are set to post the fastest growth within applications, at an 8.9% CAGR, as manufacturers use the ingredients to stabilize bakery goods, dairy products, margarine, sauces, and plant-based foods. Rising demand for low-fat, low-calorie, and clean-label products is pushing producers to rely on emulsifiers to maintain texture and shelf life without added fats or calories.

Lysaker, Norway – – October 02, 2026 -- Aker BP has named a new executive management team that will take effect on January 1, 2027, reorganizing leadership around the company's full value chain from exploration to production.

New structure splits leadership into five value-chain roles and five support functions

The value-chain leadership consists of Petter Sørhaug (Find & Develop), Tommy Sigmundstad (Build), Lars Høier (Produce), Øystein Arvesen (Optimise) and Knut Sandvik (PDO Projects). Strategic and support functions will be led by CFO David Tønne, Marit Blaasmo (Services), Thomas Hoff-Hansen (Digital), Paula Doyle (Strategic Innovation) and Rolf Nystein (Transformation). CEO Karl Johnny Hersvik continues to lead the combined team.

Vancouver – October 02, 2026 -- Trilogy Metals Inc. (NYSE American: TMQ; TSX: TMQ) closed a $17.8 million strategic equity investment from the United States Department of War (DOW) on September 11, 2026, as part of a broader $35.6 million financing package tied to its Upper Kobuk Mineral Projects (UKMP) in Alaska. The company reported a cash balance of $31.2 million and adjusted working capital of $30.3 million as of August 31, 2026, which it says substantially funds its share of Ambler Metals LLC's fiscal 2026 budget.

Delray Beach, Fla. – October 02, 2026 -- The global space sensors and actuators market is set to grow from $5.75 billion in 2026 to $9.04 billion by 2031, a 9.5% compound annual growth rate, according to a new report from MarketsandMarkets.

Sensors segment leads demand on satellite positioning and propulsion needs

By product type, sensors are estimated to lead the market, driven by their critical role in satellite positioning, propulsion control, and robotic operations. Manufacturers are advancing compact, radiation-hardened, and electromechanical sensor designs to serve both deep space and commercial missions.

Interplanetary spacecraft and probes dominate platform-level spending

The interplanetary spacecraft & probes segment is estimated to hold the largest market share by platform, as rising investment in planetary exploration missions fuels demand for advanced sensing and actuation systems.

San Diego – October 02, 2026 -- Seasats has deployed a fleet of Lightfish unmanned surface vessels into the Gulf of America for persistent maritime border surveillance, expanding a federal autonomous maritime program run under the Office of the Assistant Secretary of War for Homeland Defense and Americas Security Affairs.

Lightfish fleet launches from Texas coast into Gulf waters

Launched from the Texas coast, the autonomous fleet will conduct continuous surveillance to detect drug trafficking and unauthorized vessel incursions in the Gulf, building on the company's prior support of Operation River Wall along the southern border.

New York – October 02, 2026 -- Roland Foods, LLC will acquire Savor Brands, LLC from Dot Foods, Inc. under a strategic partnership that also gives Dot Foods an equity interest in Roland Foods, the companies announced. The deal pairs Roland Foods' 2,400-product global ingredient portfolio with Savor's frozen offerings and expanded import range, while Dot Foods will distribute both Roland and Savor products through its nationwide less-than-truckload redistribution network.

Dot Foods gains equity stake while keeping distribution role

Dot Foods, which carries 130,000 products from 1,500 manufacturers and operates 13 U.S. distribution centers plus two in Canada, will become both a shareholder in Roland Foods and its commercial distribution partner. Keith Dougherty, CEO of Roland Foods, said the Dot relationship will make it easier for customers to buy from the combined business.

Las Vegas – October 02, 2026 -- Rareview Capital LLC has launched the Rareview Bloomberg Commodity Index ETF, trading under the symbol BCOM, offering passive exposure to the Bloomberg Commodity Index Total Return.

Fund tracks 24 futures contracts across 22 commodities as of April 30, 2026

The ETF is weighted two-thirds by trading volume or liquidity and one-third by world production or global economic significance. Weight caps limit any single commodity to 15% and any sector to 33%, capping concentration risk across energy, metals, agriculture and livestock.

South San Francisco, Calif. – October 02, 2026 -- AKASA has launched an autonomous AI platform for inpatient medical coding and clinical documentation integrity (CDI), expanding beyond its existing prebill review tools after inpatient volume processed by the company grew nearly 6x over the past year.

AKASA's health system customers now cover 10% of U.S. inpatient discharges

The company's customer base collectively represents more than $180 billion in aggregate net patient revenue and roughly 10% of all U.S. inpatient discharges. The growth has been driven by adoption of AKASA's existing AI-powered prebill review products, which the company says created the volume and performance data needed to move into fully autonomous coding.

Geneva – October 02, 2026 -- The employee partnership owning Gunvor Group Ltd has voted to rename the company Centalion Group Ltd and relocate its corporate headquarters from Cyprus to Singapore, marking the next phase after a December 2025 management buyout.

Partnership referendum backs new brand after six-month review

The name change followed a full partnership referendum in July 2026, preceded by six months of employee engagement and market-positioning research conducted by brand specialist Landor. Gary Pedersen, Chairman and CEO of Centalion, said the move reflects "one team, moving together, at the heart of the global energy markets," framing it as a step taken from a position of commercial strength rather than necessity.

Nottingham, England – October 02, 2026 -- Quotient Sciences and Copenhagen-based Acesion Pharma have launched a collaboration to apply AI-enhanced formulation development to Acesion's early-stage pipeline of small molecules targeting atrial fibrillation, a condition affecting an estimated 50-60 million people globally.

AI tool uses Bayesian optimization to screen drug formulations for clinical success

The collaboration deploys Quotient Sciences' new AI-enhanced formulation development solution within its Translational Pharmaceutics platform, applying active machine learning with Bayesian optimization to identify and prioritize drug products most likely to succeed in clinical testing. The approach is designed to compress early clinical decision-making timelines for sponsors developing new treatments.

New York – October 02, 2026 -- Corporate dealmaking accelerated this week as Peoples Bancorp Inc. and Capital Bancorp, Inc. agreed to merge into a $14 billion-asset bank, and AT&T, T-Mobile and Verizon launched a joint venture aimed at eliminating mobile dead zones, underscoring consolidation pressure across financial services and telecommunications infrastructure.

Peoples Bancorp and Capital Bancorp combine into a $14 billion-asset institution

The merger agreement between Peoples Bancorp Inc. and Capital Bancorp, Inc. will create a combined entity with approximately $14 billion in total assets, $10 billion in total loans and $11 billion in total deposits. The new bank will operate more than 150 banking locations across eight states and Washington, D.C., alongside nationwide specialty financial services platforms.

Kilmarnock – October 02, 2026 -- Copenhagen Infrastructure Partners (CIP) has taken a Financial Investment Decision for Kilmarnock South, a 350 MW/1,400 MWh lithium-ion battery energy storage system in south Ayrshire, Scotland, committing over EUR 270 million (GBP 232 million) through its fourth flagship fund, Copenhagen Infrastructure IV.

Construction begins with commercial operations targeted for Q1 2028

Kilmarnock South is now under construction and is scheduled to reach commercial operations in the first quarter of 2028. At four hours of duration, it will become the longest-duration asset in CIP's UK storage portfolio once operational, designed to store surplus Scottish wind power and release it to the grid during periods of network capacity.

Dubai – October 02, 2026 -- HOP Events, the cultural entertainment platform under Dubai-based PANTHEON ACR, has announced plans to expand into 25 cities over the next 24 months, delivering more than 250 experiences annually across 75 venues and arenas to over one million attendees each year.

Expansion targets major global hubs including Dubai, London, New York, Doha and Singapore

Chairman Kalpesh Kinariwala confirmed the rollout will span 25 cities worldwide, positioning HOP Events as a regional cultural platform moving beyond standalone live entertainment into a broader community-focused ecosystem. The company frames the expansion not as a growth-for-growth's-sake strategy but as an effort to build shared cultural experiences across diverse global audiences.

Tianjin, China – October 02, 2026 -- Tianjin University's "Shengong-Shengao" system has become China's first approved brain-computer interface (BCI) medical device for diagnosing cognitive impairment, cutting diagnosis time for conditions like hydrocephalus from days to just 30 minutes. The milestone marks a commercial breakthrough as TJU, China's first modern university, marks its 131st anniversary on October 2, 2026.

Shengong device line moves from lab to clinical wards nationwide

Developed by a team led by Professor Liu Xiuyun, the Shengong-Shengao system received regulatory approval and has already been joined by more than 20 additional devices in the Shengong series now deployed in clinical settings. The university states the devices have delivered measurable benefits to thousands of patients, signaling rapid translation of university research into deployable medical hardware.